Edwards Lifesciences share price logo

Edwards Lifesciences

NASDAQ: EW

Large Cap

$92.30

+1.32

(+1.45%)

as on

Edwards Lifesciences Stock Performance

as on August 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $91.34
    $93.25
    downward going graph

    1.04%

    Downside

    1.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $72.30
    $96.29
    downward going graph

    21.67%

    Downside

    4.32%

    Upside

    downward going graph

Edwards Lifesciences share price movements today

Previous Close
$90.98
Open
$91.54
Volume
1.8M
Market Cap
$52.8B
Day's Low - High
$91.34 - $93.25
52 Week Low - High
$72.30 - $96.29

Edwards Lifesciences Historical Returns

1 Month Return
+ 6.85 %
3 Month Return
+ 12.56 %
1 Year Return
+ 17.05 %
3 Year Return
+ 19.22 %
5 Year Return
-21.88 %

Edwards Lifesciences Stock Fundamentals & Key Indicators

Check Edwards Lifesciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.8B

EPS (TTM)

1.74

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.25%

PE Ratio (TTM)

53.2

Industry PE ratio

14.834285714285715

PEG Ratio

-0.7089329904837257

EBITDA

1.5B

Revenue (TTM)

6.5B

Profit Margin

77.98%

Return On Equity TTM

9.69%

Edwards Lifesciences Stock Valuation

Track how Edwards Lifesciences P/E has moved over time to understand its valuation trends.

Edwards Lifesciences in the last 5 years

  • Overview

  • Trends

Lowest (10.61x)

December 31, 2024

Industry (14.83x)

December 31, 2025

Today (46.33x)

December 31, 2025

Highest (53.72x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 46.33x

Edwards Lifesciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Edwards Lifesciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$52.8B-21.88%53.277.98%NA
BUY$130.1B26.77%35.2214.43%102.06%
BUY$116.1B-30.2%24.1565.02%3.15%
BUY$192.5B-11.49%3611.65%222.88000000000002%
BUY$75.1B14.8%20.8471.16%NA

Stock Returns calculator for Edwards Lifesciences Stock including INR - Dollar returns

The Edwards Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edwards Lifesciences investment value today

Current value as on today

₹1,29,688

Returns

₹29,688

(+29.69%)

Returns from Edwards Lifesciences Stock

₹17,940 (+17.94%)

Dollar Impact

₹11,748 (+11.75%)

Analyst Recommendation on Edwards Lifesciences Stock

Based on 19 analysts

BUY

84.21%

Buy

15.79%

Hold

0.00%

Sell

Based on 19 analysts, 84.21052631578947% of analysts recommend a 'BUY' rating for Edwards Lifesciences. Average target price of $100.96

Edwards Lifesciences Share Price Target

Get share price movements and forecasts by analysts on Edwards Lifesciences.

What analysts predicted

8.58%UPSIDE

Target Price

$100.96

Current Price

$92.3

Analyzed by

19 Analysts

Target

$100.96

Edwards Lifesciences target price $100.96, a slight upside of 8.58% compared to current price of $92.3. According to 19 analysts rating.

Indian Investors' Interest in Edwards Lifesciences Stock

Search interest for Edwards Lifesciences Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Edwards Lifesciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1,329
1,385
1,354
1,385
1,412
1,532
1,553
1,569
1,648
1,741
Gross Profit
1,040
1,088
1,091
1,093
1,111
1,189
1,209
1,229
1,289
1,350
Operating Income
355
364
350
312
394
430
425
370
514
519
EBITDA
409
426
428
483
470
400
387
133
499
519
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
38
39
34
42
36
38
39
42
40
-
Income Before Tax
371
386
402
390
433
400
348
90
459
519
Income Tax Expense
46
20
40
45
70
64
56
26
78
278
Net Income
351
363
3,070
385
358
329
291
91
380
241
Net Profit Margin
78.25%
78.51%
80.59%
78.91%
78.65%
77.64%
77.88%
78.30%
78.21%
77.56%

Edwards Lifesciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3,435
3,722
4,348
4,386
5,232
5,382
5,010
5,439
6,067
Gross Profit
2,552
2,800
3,192
3,287
4,006
4,215
3,972
4,322
4,740
Operating Income
1,010
1,092
1,197
1,296
1,610
1,702
1,427
1,378
1,636
EBITDA
1,140
872
1,308
1,074
1,890
1,960
1,534
1,723
1,429
Interest Expense
23
33
27
22
24
26
17
19
-
Depreciation
81
77
114
135
163
166
144
155
156
Income Before Tax
1,034
761
1,166
916
1,702
1,767
1,372
1,548
1,272
Income Tax Expense
451
39
119
93
198
245
152
152
216
Net Income
622
722
1,046
823
1,503
1,521
1,402
4,174
1,073
Net Profit Margin
74.30%
75.23%
73.43%
74.94%
76.57%
78.31%
79.30%
79.46%
78.13%

Edwards Lifesciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
351
365
3,069
385
356
331
290
91
380
241
Operating Cash Flow
-53
371
351
-127
280
290
573
450
43
651
Investing Cash Flow
63
124
2,701
-576
85
-172
-427
-198
-92
-193
Financing Cash Flow
61
-96
-976
28
-258
52
-740
-11
-451
0
Change in Cash
81
429
2,035
-624
90
141
-595
244
-492
462

Edwards Lifesciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
583
722
1,046
823
1,503
1,521
1,402
4,169
1,069
Operating Cash Flow
1,000
926
1,179
1,054
1,732
1,218
895
542
1,595
Investing Cash Flow
-647
76
-595
-531
-1,722
252
173
2,312
-712
Financing Cash Flow
-473
-1,101
-115
-486
-356
-1,584
-711
-983
-956
Change in Cash
-111
-104
465
15
-332
-94
375
1,910
-119

Mutual Funds that own Edwards Lifesciences Stock

Check out the Mutual Funds with significant holdings in Edwards Lifesciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
9.750539%
56202111
VANGUARD SPECIALIZED FUNDS
2.55873%
14748525
Fidelity Concord Street Trust
1.712582%
9871325
JPMorgan Trust I
0.95999%
5533385
Fidelity Select Portfolios
0.687022%
3960000

Global Institutional Holdings in Edwards Lifesciences

Funds
Holdings
Vanguard
10.75%
iShares
6.15%
SPDR
3.98%
JPMorgan
1.13%
Invesco
0.99%

Edwards Lifesciences News & Key Events

  • img

    Today's Timeline - 30 July

    Thu, 08:03 PM

    -

    Analysts raise earnings estimates for Edwards Lifesciences, boosting Zacks Consensus Estimate from $3.03 to $3.12 per share.

    Fri, 01:50 AM

    -

    Executive files to sell 50,000 shares of Edwards Lifesciences for $4.625 million.

Insights on Edwards Lifesciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Edwards Lifesciences Corp has shown a consistent growth in revenue over the last 8 quarters. The revenue has increased from $1.35 billion to $1.74 billion, with an average quarterly growth rate of 3.5%. This upward trend indicates a positive performance for the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, EW stock has moved up by 15.3%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EW has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, EW has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Edwards Lifesciences Corp has seen a decline in its net profit over the last two quarters. The profit dropped from $380.70 million to $241.89 million, reflecting an average decrease of 36.5% per quarter.

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
OrganisationEdwards Lifesciences
HeadquartersOne Edwards Way, Irvine, CA, United States, 92614
IndustryMedical Devices
CEOMr. Bernard J. Zovighian
E-voting on sharesClick here to vote

Key Management of Edwards Lifesciences

Name

Title

Mr. Bernard J. Zovighian

CEO & Director

Mr. Joseph Nuzzolese

Corporate Vice President of Global Operations & Quality

Dr. Todd Brinton FACC, M.D.

Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer

Mr. Snehashish Sarkar

Senior VP and Chief Information & Digital Officer

Mr. Donald E. Bobo Jr.

Corporate Vice President of Strategy & Corporate Development

Mr. Daveen Chopra

Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies

Ms. Annette Maria Bruls

Corporate Vice President of EMEA, Canada, & Latin America

Ms. Theodora Mistras

Corporate VP & CFO

Mr. Andrew M. Dahl

Principal Accounting Officer, Senior VP & Corporate Controller

Mr. Mark D. Peterson

Corporate VP & General Counsel

FAQs

What is Edwards Lifesciences share price today?

Edwards Lifesciences share price today is $92.30 as on at the close of the market. Edwards Lifesciences share today touched a day high of $93.25 and a low of $91.34.

What is the 52 week high and 52 week low for Edwards Lifesciences share?

Edwards Lifesciences share touched a 52 week high of $96.29 on and a 52 week low of $72.30 on . Edwards Lifesciences stock price today i.e. is closed at $92.30,which is 4.14% down from its 52 week high and 27.66% up from its 52 week low.

What is Edwards Lifesciences's market capitalisation today?

Edwards Lifesciences market capitalisation is $0.05T as on .

How to invest in Edwards Lifesciences Stock (EW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Edwards Lifesciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edwards Lifesciences Shares that will get you 0.0163 shares as per Edwards Lifesciences share price of $92.30 per share as on August 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Edwards Lifesciences Stock (EW) from India?

Indian investors can start investing in Edwards Lifesciences (EW) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Edwards Lifesciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Edwards Lifesciences share’s latest price of $92.30 as on August 20, 2026 at 1:29 am IST, you will get 0.1083 shares of Edwards Lifesciences. Learn more about fractional shares .

What are the returns that Edwards Lifesciences has given to Indian investors in the last 5 years?

Edwards Lifesciences stock has given -21.88% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?